|
¼¼°èÀÇ Àü½Å ¸¶ÃëÁ¦ ½ÃÀå : ºÐÀÚ À¯Çü, Áö¿ªº° - ±Ô¸ð, Á¡À¯À², Àü¸Á, ±âȸ ºÐ¼®(2019-2027³â)
General Anesthesia Drugs Market, By Molecule Type and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
|
¸®¼Ä¡»ç |
Coherent Market Insights
|
¹ßÇàÀÏ |
2019³â 12¿ù |
»óǰ ÄÚµå |
920730 |
ÆäÀÌÁö Á¤º¸ |
¿µ¹® |
°¡°Ý |
|
¼¼°èÀÇ Àü½Å ¸¶ÃëÁ¦ ½ÃÀå : ºÐÀÚ À¯Çü, Áö¿ªº° - ±Ô¸ð, Á¡À¯À², Àü¸Á, ±âȸ ºÐ¼®(2019-2027³â)
General Anesthesia Drugs Market, By Molecule Type and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
|
¹ßÇàÀÏ : 2019³â 12¿ù | ÆäÀÌÁö Á¤º¸ : ¿µ¹® |
|
|
¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹®¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹®¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù. ¼¼°èÀÇ Àü½Å ¸¶ÃëÁ¦(General Anesthesia Drugs) ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå ±âȸ, Á¦Ç° ¹ß¸Å, ¿µÇ⠺м®, ¼ºÀå ¹× ÀúÇØ¿äÀÎ, ºÐÀÚ À¯Çü¡¤Áö¿ªº° ½ÃÀå ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ÀÇ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¸ñÀû¡¤ÀüÁ¦Á¶°Ç
Á¦2Àå ½ÃÀå ¹üÀ§
- ¸®Æ÷Æ® ¼³¸í
- °³¿ä
- ºÐÀÚ À¯Çüº°
- Áö¿ªº°
- Coherent Opportunity Map(COM)
Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®
- ½ÃÀå ¿ªÇÐ
- ¼ºÀå¿äÀÎ
- ÀúÇØ¿äÀÎ
- ½ÃÀå ±âȸ
- ¿µÇ⠺м®
- ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
- Á¦Ç° ¹ß¸Å
- ±ÔÁ¦ ½Ã³ª¸®¿À
- PEST ºÐ¼®
- ÇÕº´°ú Àμö
Á¦4Àå ½ÃÀå ºÐ¼® : ºÐÀÚ À¯Çüº°
- ¼·Ð
- Propofol
- Sevoflurane
- Dexmedetomidine
- Desflurane
- Remifentanil
- Midazolam
- ±âŸ
Á¦5Àå ½ÃÀå ºÐ¼® : Áö¿ªº°
- ¼·Ð
- ºÏ¹Ì
- ¶óƾ¾Æ¸Þ¸®Ä«
- À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- 秵- ¾ÆÇÁ¸®Ä«
Á¦6Àå °æÀï ±¸µµ
- ±â¾÷ °³¿ä
- Baxter International Inc.
- AstraZeneca
- AbbVie Inc.
- B. Braun Melsungen AG
- Fresenius SE & Co. KGaA
- Hospira Inc.
Á¦7Àå ¼½¼Ç
- ÂüÁ¶ ÀÚ·á
- Á¶»ç ¹æ¹ý
- Coherent Market Insights ¼Ò°³
KSA 20.01.31
Title: General Anesthesia Drugs Market, By Molecule Type (Propofol, Sevoflurane, Dexmedetomidine, Desflurane, Remifentanil, Midazolam, Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027.
General anesthesia is a therapeutically induced condition of unconsciousness; that is, loss of protective reflexes, which results from the use of one or multiple general anesthetic agents. The drug is administered to allow performing the medical procedures which are unbearably painful for the patient. A range of medicines can be administered, the overall aim of which is to ensure unconsciousness, analgesia, and loss of reflexes of the ANS or autonomic nervous system. In some cases, general anesthetic drugs are used for paralyzing the skeletal muscles.
Key features of the study::
- This report provides in-depth analysis of the General Anesthesia Drugs market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the global General Anesthesia Drugs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include, Baxter International Inc., AstraZeneca, AbbVie Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, and Hospira Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global General Anesthesia Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global General Anesthesia Drugs market
Detailed Segmentation::
- General Anesthesia Drugs Market, By Molecule Type:
- Propofol
- Sevoflurane
- Dexmedetomidine
- Desflurane
- Remifentanil
- Midazolam
- Others
- General Anesthesia Drugs Market, By Region:
- North America
- By Molecule Type:
- Propofol
- Sevoflurane
- Dexmedetomidine
- Desflurane
- Remifentanil
- Midazolam
- Others
- By Country:
- U.S.
- Canada
- Latin America
- By Molecule Type:
- Propofol
- Sevoflurane
- Dexmedetomidine
- Desflurane
- Remifentanil
- Midazolam
- Others
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Molecule Type:
- Propofol
- Sevoflurane
- Dexmedetomidine
- Desflurane
- Remifentanil
- Midazolam
- Others
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Molecule Type:
- Propofol
- Sevoflurane
- Dexmedetomidine
- Desflurane
- Remifentanil
- Midazolam
- Others
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Molecule Type:
- Propofol
- Sevoflurane
- Dexmedetomidine
- Desflurane
- Remifentanil
- Midazolam
- Others
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Molecule Type:
- Propofol
- Sevoflurane
- Dexmedetomidine
- Desflurane
- Remifentanil
- Midazolam
- Others
- By Country:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Baxter International Inc. *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- AstraZeneca
- AbbVie Inc.
- B. Braun Melsungen AG
- Fresenius SE & Co. KGaA
- Hospira Inc.
"*" marked represents similar segmentation in other categories in the respective section. Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Molecule Type
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Product launch
- Regulatory Scenario
- PEST Analysis
- Mergers and Acquisitions
4. Global General Anesthesia Drugs Market, By Molecule Type, 2019 - 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 - 2027
- Segment Trends
- Propofol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
- Keratolytics
- Moisturizers
- Retinoids
- SunScreens
- Hair Removals
- Sevoflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
- Dexmedetomidine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
- Desflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
- Remifentanil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
- Midazolam
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
5. Global General Anesthesia Drugs Market, By Region, 2019 - 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2026
- North America
- Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
- South Africa
- Central Africa
- North Africa
6. Competitive Landscape
- Company Profiles
- Baxter International Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AstraZeneca
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AbbVie Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- B. Braun Melsungen AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Fresenius SE & Co. KGaA
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Hospira Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
7. Section
- References
- Research Methodology
- About us and Sales Contact
|

|
¼¼°èÀÇ ±¹¼Ò¸¶ÃëÁ¦ ½ÃÀå(2020-2027³â)
¼¼°èÀÇ ¸¶ÃëÁ¦ ½ÃÀå : ¼ºÀå, µ¿Çâ, ¿¹Ãø(2019-2024³â)
¼¼°èÀÇ ±¹¼Ò¸¶ÃëÁ¦ ½ÃÀå : ¸¶ÃëÁ¦ Á¾·ù ¹× ¿ëµµº° ºÐ¼® - ¼ºÀå, µ¿Çâ, ¿¹Ãø(2018-2023³â)
¼¼°èÀÇ ¸¶ÃëÁ¦ ½ÃÀå ¿¹Ãø
¹Ì±¹ÀÇ ¸¶ÃëÁ¦ ½ÃÀå ¹× ¿¹Ãø
±¹¼Ò¸¶ÃëÁ¦ ½ÃÀå ºÐ¼® : Á¦Ç°º°, ¿ëµµº°, ºÎ¹®º° ¿¹Ãø
¼¼°èÀÇ ¸¶ÃëÁ¦ ½ÃÀå : ÀλçÀÌÆ®, ±âȸ ºÐ¼®, ½ÃÀå Á¡À¯À², ¿¹Ãø
¼¼°èÀÇ Àü½Å ¸¶ÃëÁ¦ ½ÃÀå : ¼ºÀå·ü, µ¿Çâ ¹× ¿¹Ãø
|